Judge Finds Drug Makers Liable For Inflating Costs

Law360, New York (June 21, 2007, 12:00 AM EDT) -- A federal judge has issued a stinging rebuke to three pharmaceutical companies in a massive antitrust class action, finding that they acted unfairly and deceptively by causing the publication of artificially inflated average wholesale prices for various prescription drugs.

After a twenty-day bench trial, U.S. District Judge Patti B. Saris said in findings of fact and conclusions of law filed Thursday that AstraZeneca, Bristol-Myers Squibb Co. and Schering-Plough Corp., a subsidiary of Warrick, inflated the AWP for the drugs, which grossly exceeded actual physician acquisition costs....
To view the full article, register now.